Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect?
- 27 September 2002
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 330 (3) , 251-254
- https://doi.org/10.1016/s0304-3940(02)00823-6
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Effects of enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slicesPublished by Elsevier ,2002
- Enantioselektive Gewinnung und Kristallstruktur des Ecstasy-Analogons N-Ethyl-3,4-methylendioxyamphetamin-HCl (MDE) und seiner beiden Hauptmetaboliten MDA und HME / Enantioselective Production and Crystal Structure of the Ecstasy Analogue N-Ethyl-3,4- methylenedioxyamphetamine-HCl (MDE) and its Major Metabolites MDA and HMEZeitschrift für Naturforschung B, 2000
- Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotoninSynapse, 2000
- De Novo Onset of Parkinson's Disease After Antidepressant Treatment With CitalopramPharmacopsychiatry, 2000
- Serotonergic mechanisms in neuroleptic-induced catalepsy in the ratNeuroscience & Biobehavioral Reviews, 1996
- Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptorEuropean Journal of Pharmacology, 1988